stella
beta
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks — Stella
Recruiting
Back to Breast Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
the Second Affiliated Hospital of Zhejiang Univercity School of Medicine, Hanzhou, Zhejiang
View full record on ClinicalTrials.gov